Seyed–Omar Zaraei

548 citations

36 papers · 385 indexed · h-index 14

Organic Chemistry top 10%
Molecular Biology
Oncology
Computational Theory and Mathematics top 10%
Pharmacology

Co-authors: Hanan S. Anbar Mohammed I. El‐Gamal Mohammed I. El–Gamal Sumera Zaib Chang‐Hyun Oh Jamshed Iqbal Hamadeh Tarazi Jean Sévigny
Topics: Synthesis and biological activity (9 papers)Enzyme function and inhibition (6 papers)Melanoma and MAPK Pathways (6 papers)
Cited by: Organic Chemistry Physiology Molecular Biology
Journals: PLoS ONE Journal of Agricultural and Food Chemistry Molecules
Partner nations: Egypt United Arab Emirates South Korea

In The Last Decade

Seyed–Omar Zaraei

34 papers receiving 380 citations

Peers

Countries citing papers authored by Seyed–Omar Zaraei

Since Specialization

Citations

This map shows the geographic impact of Seyed–Omar Zaraei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seyed–Omar Zaraei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seyed–Omar Zaraei more than expected).

Fields of papers citing papers by Seyed–Omar Zaraei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seyed–Omar Zaraei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seyed–Omar Zaraei. The network helps show where Seyed–Omar Zaraei may publish in the future.

Co-authorship network of co-authors of Seyed–Omar Zaraei

This figure shows the co-authorship network connecting the top 25 collaborators of Seyed–Omar Zaraei. A scholar is included among the top collaborators of Seyed–Omar Zaraei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seyed–Omar Zaraei. Seyed–Omar Zaraei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of Glucosinolate Sulfatases to Combat Plutella xylostella: Development of Novel Phenylcarboxamide Derivatives for Plant-Integrated Pest Management 2025 ·Journal of Agricultural and Food Chemistry ·Jiali Wang,(unknown),(unknown),Seyed–Omar Zaraei,(unknown),Yingjie Wen,(unknown),Mohammed I. El‐Gamal,Hanhong Xu	0
2	Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives 2023 ·Molecular and Biochemical Parasitology ·Ruqaiyyah Siddiqui,Mohammed I. El–Gamal,(unknown),Seyed–Omar Zaraei,Naveed Ahmed Khan	1
3	Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells 2023 ·European Journal of Medicinal Chemistry ·(unknown),Mohammed S. Abdel‐Maksoud,Eslam M.H. Ali,Usama M. Ammar,Seyed–Omar Zaraei,Md. Mamunul Haque,(unknown),(unknown),Eunice EunKyeong Kim,Jun‐Seok Lee,HaJeung Park,Kwan H. Lee,Mohammed I. El–Gamal,Hee-Kwon Kim,Tamer M. Ibrahim,Chang‐Hyun Oh	8
4	The anti-amoebic potential of carboxamide derivatives containing sulfonyl or sulfamoyl moieties against brain-eating Naegleria fowleri 2023 ·Parasitology Research ·Noor Akbar,Ruqaiyyah Siddiqui,Mohammed I. El‐Gamal,Seyed–Omar Zaraei,(unknown),Naveed Ahmed Khan	2
5	The latest perspectives of small molecules FMS kinase inhibitors 2023 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),Seyed–Omar Zaraei,(unknown),Taleb H. Al‐Tel,Mohammed I. El‐Gamal	0
6	Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations 2023 ·Antibiotics ·Ruqaiyyah Siddiqui,Mutasem Rawas‐Qalaji,Mohammed I. El–Gamal,(unknown),(unknown),Seyed–Omar Zaraei,(unknown),Hanan S. Anbar,Wolfgang Döhle,Barry V. L. Potter,Naveed Ahmed Khan	5
7	Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study 2022 ·European Journal of Pharmaceutical Sciences ·Eslam M.H. Ali,(unknown),Usama M. Ammar,Seyed–Omar Zaraei,Mohammed S. Abdel‐Maksoud,Mohammed I. El–Gamal,Md. Mamunul Haque,(unknown),Eunice EunKyeong Kim,Jun‐Seok Lee,Kwan H. Lee,Hee-Kwon Kim,Chang‐Hyun Oh	13
8	Design and synthesis of new adamantyl derivatives as promising antiproliferative agents 2022 ·European Journal of Medicinal Chemistry ·(unknown),Seyed–Omar Zaraei,(unknown),Saif Ullah,Hanan S. Anbar,(unknown),Varsha Menon,Mohammed S. Abdel‐Maksoud,Chang‐Hyun Oh,Raafat El‐Awady,Nicolly Espíndola Gelsleichter,Julie Pelletier,Jean Sévigny,Jamshed Iqbal,Taleb H. Al‐Tel,Mohammed I. El‐Gamal	7
9	Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity 2022 ·European Journal of Medicinal Chemistry ·Seyed–Omar Zaraei,(unknown),Hanan S. Anbar,(unknown),Hamadeh Tarazi,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Raafat El‐Awady,Taleb H. Al‐Tel,Mohammed I. El‐Gamal	18
10	Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors 2022 ·Bioorganic & Medicinal Chemistry ·(unknown),Anusha Sebastian,Vunnam Srinivasulu,(unknown),Hamadeh Tarazi,Hanan S. Anbar,(unknown),Seyed–Omar Zaraei,Sara M. Elgendy,(unknown),Hany A. Omar,Taleb H. Al‐Tel,Mohammed I. El–Gamal	9
11	Anti-amoebic activity of a series of benzofuran/benzothiophene derivatives againstAcanthamoeba castellaniibelonging to the T4 genotype 2022 ·Journal of Applied Microbiology ·Noor Akbar,Mohammed I. El–Gamal,Seyed–Omar Zaraei,Balsam Qubais Saeed,Naveed Ahmed Khan,Ruqaiyyah Siddiqui	2
12	Potent Imidazothiazole-based Inhibitor of BRAF V600E Overcomes Acquired Resistance via Inhibition of RAF Dimerization in PLX4032-resistant Melanoma 2022 ·Anticancer Research ·(unknown),(unknown),(unknown),Seung Yong Shin,Seyed–Omar Zaraei,Chang‐Hyun Oh,Hong Seok Choi	3
13	A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors 2021 ·Molecules ·Mohammed I. El–Gamal,(unknown),(unknown),(unknown),Hamadeh Tarazi,(unknown),(unknown),Seyed–Omar Zaraei,(unknown),Hanan S. Anbar	38
14	Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAFV600E/p38α inhibitors 2021 ·European Journal of Medicinal Chemistry ·Eslam M.H. Ali,(unknown),Mohammed S. Abdel‐Maksoud,Usama M. Ammar,(unknown),Seyed–Omar Zaraei,Mohammed I. El‐Gamal,(unknown),Kyung‐Tae Lee,Hee-Kwon Kim,Kwan H. Lee,Chang‐Hyun Oh	24
15	Discovery of urease inhibitory effect of sulfamate derivatives: Biological and computational studies 2021 ·Bioorganic Chemistry ·Sumera Zaib,(unknown),Seyed–Omar Zaraei,Imtiaz Khan,Hanan S. Anbar,Mohammed I. El‐Gamal	15
16	Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors 2021 ·European Journal of Medicinal Chemistry ·Seyed–Omar Zaraei,(unknown),(unknown),Hanan S. Anbar,(unknown),Hamadeh Tarazi,(unknown),Mohammed S. Abdel‐Maksoud,Chang‐Hyun Oh,Mohammed I. El–Gamal	21
17	A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation 2020 ·Bioorganic & Medicinal Chemistry ·Mohammed I. El‐Gamal,Seyed–Omar Zaraei,Paul Foster,Hanan S. Anbar,(unknown),Raafat El‐Awady,Barry V. L. Potter	16
18	Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II/IX/XII inhibitors 2019 ·Bioorganic & Medicinal Chemistry ·Seyed–Omar Zaraei,Mohammed I. El‐Gamal,Zainab Shafique,(unknown),Saifullah Afridi,Sumera Zaib,Hanan S. Anbar,(unknown),Jamshed Iqbal	12
19	Sulfamates in drug design and discovery: Pre-clinical and clinical investigations 2019 ·European Journal of Medicinal Chemistry ·Seyed–Omar Zaraei,Abduelmula R. Abduelkarem,Hanan S. Anbar,(unknown),(unknown),(unknown),Mohammed I. El‐Gamal	26
20	Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase 2019 ·European Journal of Medicinal Chemistry ·Mohammed I. El–Gamal,Saif Ullah,Seyed–Omar Zaraei,(unknown),Sumera Zaib,Dana M. Zaher,Hany A. Omar,Hanan S. Anbar,Julie Pelletier,Jean Sévigny,Jamshed Iqbal	25

About Seyed–Omar Zaraei

Seyed–Omar Zaraei is a scholar working on Endocrinology, Physiology and Organic Chemistry, having authored 36 papers that have together received 385 indexed citations. Recurring topics across this work include Synthesis and biological activity (9 papers), Enzyme function and inhibition (6 papers) and Melanoma and MAPK Pathways (6 papers). The work is most often cited by research in Organic Chemistry (210 citations), Physiology (30 citations) and Molecular Biology (201 citations). Seyed–Omar Zaraei has collaborated with scholars based in Egypt, United Arab Emirates and South Korea. Frequent co-authors include Hanan S. Anbar, Mohammed I. El‐Gamal, Mohammed I. El–Gamal, Sumera Zaib, Chang‐Hyun Oh, Jamshed Iqbal, Hamadeh Tarazi, Jean Sévigny, Saif Ullah and Julie Pelletier. Their work appears in journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact